Stay updated on BLASST-1: Nivolumab Combo in MIBC Clinical Trial
Sign up to get notified when there's something new on the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page.

Latest updates to the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.5.2 updated from v3.5.0.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check38 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check52 days agoChange DetectedCore study content (inclusion criteria, outcomes, locations, and interventions) appears unchanged; the updates seem limited to layout and formatting changes.SummaryDifference0.1%

- Check66 days agoChange DetectedAdded Revision: v3.4.2 and removed older admin notices (lapse in government funding and Revision: v3.4.1); these changes are administrative and do not affect study details, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check74 days agoChange DetectedThe page now shows a government funding lapse notice with operating status information and a new revision tag (v3.4.1) replacing the previous v3.4.0; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to BLASST-1: Nivolumab Combo in MIBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page.